Q11 Anophthalmos, microphthalmos and macrophthalmos

Name of the Condition

• Anophthalmos, microphthalmos and macrophthalmos

Summary

Anophthalmos, microphthalmos, and macrophthalmos are congenital eye conditions affecting the size and development of the eye. Anophthalmos involves the absence of ocular tissue, microphthalmos is characterized by a smaller-than-normal eye, and macrophthalmos refers to an abnormally large eye. These conditions result from disruptions in eye development during fetal growth and may be associated with other ocular or systemic anomalies.

Causes

These conditions are primarily caused by genetic mutations or chromosomal abnormalities that disrupt normal eye development. Environmental factors, such as maternal infections or exposure to teratogens during pregnancy, may also contribute. In some cases, the cause remains unknown.

Risk Factors

• Genetic predisposition or family history of eye malformations.
• Maternal infections during pregnancy (e.g., rubella, toxoplasmosis).
• Exposure to harmful substances (e.g., alcohol, certain medications) during pregnancy.
• Chromosomal disorders (e.g., trisomy 13).

Symptoms

• Absence of the eye (anophthalmos) or abnormally small (microphthalmos) or large (macrophthalmos) eye.
• Associated ocular anomalies (e.g., coloboma, cataracts).
• Vision impairment or blindness, depending on severity.
• Facial asymmetry or orbital underdevelopment.

Diagnosis

Prenatal ultrasound may detect severe cases. Postnatal diagnosis involves physical examination, ophthalmic evaluation, and imaging (e.g., MRI, CT) to assess eye structure and associated anomalies. Genetic testing may be used to identify underlying causes.

Treatment Options

Treatment focuses on managing symptoms and supporting visual development. Options may include prosthetic devices for anophthalmos, corrective lenses or surgery for microphthalmos, and monitoring for complications in macrophthalmos. Multidisciplinary care (e.g., ophthalmology, genetics) is often required.

Prognosis and Follow-Up

Prognosis varies based on severity and associated conditions. Early intervention and regular monitoring can improve outcomes. Long-term follow-up with eye care specialists and other providers is essential to address vision, developmental, or systemic issues.

Complications

• Severe vision loss or blindness.
• Orbital underdevelopment or facial asymmetry.
• Associated systemic anomalies (e.g., cardiac, neurological).
• Psychological or social challenges related to appearance.

Lifestyle & Prevention

• Genetic counseling for families with a history of eye malformations.
• Prenatal care to minimize exposure to teratogens.
• Early intervention services for developmental support.
• Adaptive strategies for vision impairment, if present.

When to Seek Professional Help

Seek immediate medical evaluation if a newborn has an absent, abnormally small, or large eye, or if vision problems are suspected. Prompt assessment by an ophthalmologist and geneticist is recommended to guide management.

Tips for Medical Coders

Document the specific subtype (anophthalmos, microphthalmos, or macrophthalmos) and any associated anomalies. Include details on laterality (e.g., right/left eye) and whether the condition is isolated or part of a syndrome. Ensure documentation supports the clinical findings and aligns with ICD-10-CM coding guidelines for Q11.